UTIs are the most common type of HAI that occur after urinary catheterization. The placement of a catheter into the urinary bladder through the urethra to deliver medication and to empty urine is known as catheterization. A healthy urinary bladder is sterile with no harmful micro-organisms or another bacteria present. Although bacteria may surround the urethra, they cannot enter the bladder. However, a catheter can pick up bacteria from the urethra and give them an easy route to enter the bladder, which causes infection. The most common UTI infections are caused by the bacteria present in the intestinal tract. Patients who take antibiotics and with a weak immune system have a high risk for UTI caused by a fungus called candida.

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 06: Market segmentation by technology

Market overview

Conventional method

Imaging tests

Point of care testing

PART 07: Market segmentation by product

Market overview

Assay kits and consumables

Instruments

PART 08: Market segmentation by end-user

Market overview

Hospitals and outpatient department

Diagnostic clinical laboratory

PART 09: Geographical segmentation

Hospital-acquired urinary tract infection testing market in

Americas

Hospital-acquired urinary tract infection testing market in

EMEA

Hospital-acquired urinary tract infection testing market in

APAC

PART 10: Market drivers

Rising prevalence of hospital-acquired UTI increases

patient volume

Favorable reimbursements of urinary catheter increase

catheter usage

Focus on disease management

Technological advances increase adoption rate of testing

devices

PART 11: Impact of drivers

PART 12: Market challenges

Growing preference over alternative products such as

anti-infection catheters

Stringent regulatory policies restrict new technologies to

enter market

Lack of healthcare infrastructure

Lack of awareness of HAIs

PART 13: Impact of drivers and challenges

PART 14: Market trends

Increased use of rapid diagnosis testing

Increasing demand of infection control committee in

hospitals

Focus on early diagnosis

PART 15: Vendor landscape

Competitive scenarios

PART 16: Key vendor analysis

bioMerieux

Roche Diagnostics

Siemens Healthineer

Other prominent vendors

PART 17: Appendix

List of abbreviations

PART 18: Explore Technavio